siRNA treatment reduces triglycerides in clients along with uncommon problem

.STUDY EMPHASIZE.19 September 2024.

Plozasiran decreased triglyceride amounts through 80% and decreased the risk of pancreatitis in patients with consistent chylomicronemia, with or even without a hereditary medical diagnosis.